Mode
Text Size
Log in / Sign up

Telemedicine May Improve Pain and Function in Arthritis PatientsTelemedicine helps manage pain for patients with arthritis conditions

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Telemedicine may improve arthritis symptoms, but low evidence certainty limits definitive conclusions.

A meta-analysis of 2,262 patients with osteoarthritis (OA) and inflammatory arthritis (IA) examined telemedicine's impact on pain, quality of life, WOMAC scores, and self-efficacy. Results showed significant improvements across all outcomes, with effect sizes ranging from small to moderate. For pain, the standardized mean difference (SMD) was -0.66 (95% CI -1.00 to -0.32), indicating a moderate reduction. Quality of life improved with an SMD of 0.42 (95% CI 0.12 to 0.71), and WOMAC scores showed an SMD of -0.78 (95% CI -1.19 to -0.37). Self-efficacy also improved (SMD 0.47, 95% CI 0.06 to 0.89).

However, substantial heterogeneity (I2 > 75%) was present, and 95% prediction intervals for all outcomes included the null, suggesting the true effect in future settings could be zero or even negative. The self-efficacy finding was not robust in leave-one-out sensitivity analyses. Evidence for IA was limited to a few small trials and rated very low to low certainty.

No safety data were reported. The findings are exploratory and should not be overinterpreted. Clinicians should consider telemedicine as a potential option for managing arthritis symptoms, but further high-quality trials are needed to confirm efficacy and safety, especially for inflammatory arthritis.

How this fits prior evidence

This meta-analysis addresses a gap in managing non-pharmacological interventions for osteoarthritis and inflammatory arthritis. While prior coverage noted that non-steroidal anti-inflammatory drugs are a predictably effective first-line pharmacologic therapy for canine osteoarthritis, this study explores telemedicine as a potential adjunct for human patients. The findings for inflammatory arthritis are of low certainty and insufficient to draw definitive conclusions, similar to the low certainty noted in prior evidence regarding exercise and psoriatic arthritis.

Living with chronic joint pain can make daily life feel like a constant uphill battle. New data suggests that telemedicine, or healthcare delivered remotely, may offer a helpful way to manage these symptoms. The analysis looked at patients with osteoarthritis and inflammatory arthritis, including conditions like rheumatoid arthritis and ankylosing spondylitis.

For those with osteoarthritis, the data showed improvements in pain, quality of life, and self-efficacy. Patients also saw better scores on the WOMAC scale, which is a tool used to measure physical function and pain. However, the evidence for inflammatory arthritis is much less certain because it came from only a small number of trials.

It is important to keep these findings in perspective. Because the data comes from many different types of studies, the results are still considered exploratory. While the numbers look positive for some, the evidence is not yet strong enough to make definitive claims for everyone with inflammatory arthritis. Talk to your doctor to see if remote care fits your specific needs.

What this means for you:
Telemedicine can help reduce pain and improve quality of life for some patients with osteoarthritis.

Common questions

Can telemedicine help with my arthritis pain?

The data shows that telemedicine led to an improvement in pain for patients with osteoarthritis. However, the evidence for inflammatory arthritis is currently limited by a small number of trials, meaning the results for those specific conditions are less certain.

What other benefits does remote care offer for joint issues?

In addition to pain relief, the study found improvements in quality of life and self-efficacy for those with osteoarthritis. These measures help track how well a person functions and feels in their daily life.

Is the evidence for these results very strong?

The findings are currently considered exploratory. Because the data comes from many different types of studies, the evidence for inflammatory arthritis is rated as low to very low certainty. You should discuss these options with your doctor.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
Osteoarthritis (OA) and inflammatory arthritis (IA) are prevalent chronic musculoskeletal disorders that cause persistent pain, functional impairment, and reduced quality of life. Telemedicine offers a potential strategy for long-term arthritis management, but the strength of the supporting evidence remains uncertain. This systematic review and meta-analysis evaluated the efficacy of telemedicine interventions in patients with OA and IA. We searched PubMed, Embase, Cochrane Library, Web of Science, and WHO ICTRP up to 10 July 2026 for randomized controlled trials (RCTs). Two reviewers independently conducted study selection, data extraction, and risk-of-bias assessment using the RoB 2.0 tool. Random-effects meta-analysis was performed to calculate standardized mean differences (SMDs) with 95% confidence intervals (CIs) and 95% prediction intervals (PIs). The certainty of evidence was rated using the GRADE framework. Twenty-four RCTs enrolling 2,262 patients (1,568 with OA and 694 with IA) were included. Telemedicine was associated with improvements in pain (SMD = −0.66, 95% CI −1.00 to −0.32; 95% PI −1.90 to 0.58), quality of life (SMD = 0.42, 95% CI 0.12 to 0.71; 95% PI −0.60 to 1.44), WOMAC scores (SMD = −0.78, 95% CI −1.19 to −0.37; 95% PI −2.25 to 0.69), and self-efficacy (SMD = 0.47, 95% CI 0.06 to 0.89; 95% PI −1.04 to 1.98). All primary outcomes showed substantial heterogeneity (I2 > 75%), with 95% PIs that spanned the null value, indicating that the true effect in future studies could be zero or even negative. The self-efficacy finding lacked robustness in leave-one-out sensitivity analyses and was susceptible to the influence of individual studies. Evidence for IA was restricted to a small number of trials on rheumatoid arthritis and ankylosing spondylitis, and the overall certainty of evidence was rated very low to low. Current evidence suggests an association between telemedicine and improved outcomes in arthritis, but these findings are exploratory and limited by low evidence certainty, marked heterogeneity, and wide prediction intervals. Evidence for IA is insufficient to draw definitive conclusions. https://www.crd.york.ac.uk/PROSPERO/view/CRD420261401824, PROSPERO CRD420261401824.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.